Genespire Reports Preclinical Data Supporting Immune-Shielded Lentiviral Gene Therapy for MMA
July 08, 2026 — Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy, announced the publication of preclinical data supporting its liver-directed…
Read the full articleYou might also wanna read
Apertura Enters CRADA with NIH Institutes to Evaluate BBB-Crossing AAV Capsid for NPC1 Gene Therapy
PackGene Biotech·1d ago
Atsena Selects Lead Candidate for Dual-Vector AAV Gene Therapy Program in Stargardt Disease
PackGene Biotech·1d ago
Allotera Therapeutics Raises Additional $35M to Advance Off-the-Shelf CAR-T Therapy for T-Cell Cancers
PackGene Biotech·2d ago
Engineered AAV5 Vectors Use Glymphatic Delivery to Target Human Glial Cells Across the Brain
PackGene Biotech·2d ago
Epicrispr Completes Dose Escalation in First-in-Human AAV Gene Therapy Trial for FSHD
PackGene Biotech·3d ago
FDA Clears IND for CoRegen’s CRISPR-Engineered Treg Cell Therapy in Advanced Solid Tumors
PackGene Biotech·3d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.